ABC | Volume 115, Nº1, July 2020

Review Article Costa et al. Cardiovascular Imaging and Interventional Procedures Arq Bras Cardiol. 2020; 115(1):111-126 34. Zhu T, Wang Y, Zhou S, Zhang N, Xia L. A Comparative study of chest computed tomography features in young and older adults with corona virus disease (COVID-19). J Thorac Imaging. 2020Mar 31. [Epub ahead of print] 35. Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020 Mar 19. [Epub ahead of print] 36. Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020;47(5):1275-80. 37. Choi AD, Abbara S, Branch KR, Feuchtner GM, Ghoshhajra B, Nieman K, et al. Society of Cardiovascular Computed Tomography guidance for use of cardiac computed tomography amidst the COVID-19 pandemic endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr. 2020 Mar 21;pii:S1934-5925(20)30125-8. 38. Sara L, Tachibana A, Shiozaki AA, Villa AV, Oliveira AC, Albuquerque AS, et al. II Diretriz de Ressonância Magnética e tomografia computadorizada cardiovascular da Sociedade Brasileira deCardiologia e doColégio Brasileiro de Radiologia. Arq Bras Cardiol. 2014;103(6 Supl. 3):1-56. 39. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45(3):230-2. 40. Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, et al. Acutemyocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020Apr 8;pii:ehaa286. [Epub ahead of print] 41. Yang F, Wang J, Li W, Xu Y, Wan K, Zeng R, et al. The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysis. Eur Radiol. 2020;30(5):2616-26. 42. Aquaro GD, Perfetti M, Camastra G, Monti L, Dellegrottaglie S, Moro C, et al. Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study. J Am Coll Cardiol. 2017;70(16):1977-87. 43. Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158-76. 44. Kramer CM, Barkhausen J, Bucciarelli-Ducci C, FlammSD, KimRJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):1-17. 45. Society for Cardiovascular Magnetic Resonance [Internet]. SCMR’S COVID-19 PREPAREDNESS TOOLKIT; 2020. [citado 22 mar. 2010]. Disponível em: https://scmr.org/page/COVID19. 46. MaronDJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, BodenWE, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382(15):1395-1407. 47. Brasil.ConselhoFederaldeMedicina. OFÍCIOCFMnº1756/2020–COJUR, de 19 de março de 2020.’Decidiu aperfeiçoar ao máximo a eficiência dos serviços médicos restados e, EM CARATER DE EXCEPCIONALIDADE E ENQUANTO DURAR A BATALHA DE COMBATE AO CONTÁGIO DA COVID-19”, reconhecer a possibilidade e a eticidade da utilização da telemedicina alemdo disposto na Resolução CFMn.1643 de 26 de Agosto de 2002, no estritos e seguintes termos: teleorientação/telemonitoramento/ teleinterconsulta. 48. Avezum Junior A, Feldman A, Carvalho AC, Sousa AC, Mansur AP, Bozza AE, et al. V Guideline of the Brazilian Society of Cardiology on acute myocardial infarction treatment with ST segment elevation. ArqBras Cardiol. 2015;105(2 Suppl 1):1-105. 49. Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital. Intensive Care Med. 2020 Mar 11. [Epub ahead of print] 50. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: fromACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020;75(18):2372-5. 51. Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, et al. ST- Segment elevation in patients with Covid-19 - a case series. N Engl J Med. 2020 Apr 17. [Epub ahead of print] 52. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. NEngl J Med. 2000;343(9):611-7. 53. Tarasoutchi F, Montera MW, Ramos AIO, Sampaio RO, Rosa VEE, Accorsi TAD, et al. Atualização das diretrizes brasileiras de valvopatias: abordagem das lesões anatomicamente importantes. Arq Bras Cardiol. 2017;109(6 suppl 2):1-34. 54. Guimaraes HP, Timerman S, Correa T, Rodrigues RR, Freitas AP, Rea Neto A. Recomendaçespararessuscitaçocardiopulmonar (RCP)depacientescom diagnostico ou suspeita de COVID-19. Associaço Brasileira de Medicina de Emergencia (ABRAMEDE), Associaço de Medicina Intensiva Brasileira (AMIB), Sociedade Brasileira de Cardiologia (SBC). 2020:1-3. 55. Szerlip M, Anwaruddin S, Aronow HD, Cohen MG, Daniels MJ, Dehghani P, et al. Considerations for cardiac catheterization laboratory procedures during the COVID-19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging LeaderMentorship (SCAI ELM) Members andGraduates. Catheter Cardiovasc Interv. 2020Mar 25. [Epub ahead of print] 56. Tarantini G, Fraccaro C, Chieffo A, Marchese A, Tarantino FF, Rigattieri S, et al. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19. Catheter Cardiovasc Interv. 2020 Mar 29. [Epub ahead of print] 125